The Future of Multiple Myeloma Treatment: Dr. Atlassius Galanopoulos on Innovations in Immunotherapy, CAR-T Therapy, and Early Detection.
Advancements in Multiple Myeloma Treatment with Dr. Atlassius Galanopoulos
Massive Bio invites you to an insightful webinar on Multiple Myeloma, featuring Dr. Atlassius Galanopoulos, an esteemed hematologist specializing in malignant and non-malignant hematologic diseases.
Dr. Galanopoulos will provide valuable insights into the diagnosis, staging, and treatment options for multiple myeloma, highlighting the latest advancements in immunotherapy, targeted therapies, and CAR-T cell therapy. He will also discuss the role of stem cell transplantation and the importance of early detection in improving patient outcomes.
What to Expect:
- Understanding Multiple Myeloma and its progression
- Symptoms & early detection: What patients need to know
- Stages of multiple myeloma and their impact
- Innovations in treatment: Immunotherapy, monoclonal antibodies & targeted therapies
- The role of CAR-T therapy and its future potential
- Managing side effects for better patient outcomes
- Clinical trials: Expanding access to emerging therapies
This session is a valuable opportunity for patients, caregivers, and healthcare professionals to gain practical insights that can enhance treatment decisions and improve patient care.
Meet the Speakers

Dr. Athanasios Galanopoulos
Hematologist

Fiona Evans
Director, Patient Relations
Discover Your Options, Today
Interested in learning more about how clinical trials could be part of your cancer care strategy?
Let’s explore opportunities for your best options, together.
Discover your personalized cancer clinical trials options
Discover your personalized cancer clinical trials options
Advancements in Multiple Myeloma Treatment with Dr. Atlassius Galanopoulos
Massive Bio invites you to an insightful webinar on Multiple Myeloma, featuring Dr. Atlassius Galanopoulos, an esteemed hematologist specializing in malignant and non-malignant hematologic diseases.
Dr. Galanopoulos will provide valuable insights into the diagnosis, staging, and treatment options for multiple myeloma, highlighting the latest advancements in immunotherapy, targeted therapies, and CAR-T cell therapy. He will also discuss the role of stem cell transplantation and the importance of early detection in improving patient outcomes.
What to Expect:
- Understanding Multiple Myeloma and its progression
- Symptoms & early detection: What patients need to know
- Stages of multiple myeloma and their impact
- Innovations in treatment: Immunotherapy, monoclonal antibodies & targeted therapies
- The role of CAR-T therapy and its future potential
- Managing side effects for better patient outcomes
- Clinical trials: Expanding access to emerging therapies
This session is a valuable opportunity for patients, caregivers, and healthcare professionals to gain practical insights that can enhance treatment decisions and improve patient care.
Meet the Speakers

Dr. Athanasios Galanopoulos
Hematologist

Fiona Evans
Director, Patient Relations